IGEA Pharma N.V. IGPH.SW Stock
IGEA Pharma N.V. Price Chart
IGEA Pharma N.V. IGPH.SW Financial and Trading Overview
| IGEA Pharma N.V. stock price | 0.0015 CHF |
| Previous Close | 0.005 CHF |
| Open | 0.006 CHF |
| Bid | 0 CHF x 0 |
| Ask | 0.005 CHF x 0 |
| Day's Range | 0.005 - 0.006 CHF |
| 52 Week Range | 0.004 - 0.12 CHF |
| Volume | 3.51M CHF |
| Avg. Volume | 281.49K CHF |
| Market Cap | 2.01M CHF |
| Beta (5Y Monthly) | -0.314389 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 CHF |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IGPH.SW Valuation Measures
| Enterprise Value | 2.61M CHF |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 22.101707 |
| Price/Book (mrq) | 0.1724138 |
| Enterprise Value/Revenue | 28.78 |
| Enterprise Value/EBITDA | N/A |
Trading Information
IGEA Pharma N.V. Stock Price History
| Beta (5Y Monthly) | -0.314389 |
| 52-Week Change | -95.049% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.12 CHF |
| 52 Week Low | 0.004 CHF |
| 50-Day Moving Average | 0.00818 CHF |
| 200-Day Moving Average | 0.03 CHF |
IGPH.SW Share Statistics
| Avg. Volume (3 month) | 281.49K CHF |
| Avg. Daily Volume (10-Days) | 0 CHF |
| Shares Outstanding | 334.47M |
| Float | 2.27M |
| Short Ratio | N/A |
| % Held by Insiders | 57.30% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -934.91% |
| Gross Margin | 29.62% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -8.97% |
| Return on Equity (ttm) | -15.82% |
Income Statement
| Revenue (ttm) | 90.8K CHF |
| Revenue Per Share (ttm) | 0 CHF |
| Quarterly Revenue Growth (yoy) | -68.70% |
| Gross Profit (ttm) | -22900 CHF |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -741000 CHF |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 94.7K CHF |
| Total Cash Per Share (mrq) | 0 CHF |
| Total Debt (mrq) | 1.06M CHF |
| Total Debt/Equity (mrq) | 10.96 CHF |
| Current Ratio (mrq) | 1.067 |
| Book Value Per Share (mrq) | 0.029 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -221400 CHF |
| Levered Free Cash Flow (ttm) | -1267552 CHF |
Profile of IGEA Pharma N.V.
| Country | Switzerland |
| State | N/A |
| City | Hoofddorp |
| Address | Siriusdreef 17 |
| ZIP | 2132 WT |
| Phone | 31 23 568 9494 |
| Website | https://www.igeapharma.nl |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
IGEA Pharma N.V. commercializes health-tech and med-tech products and devices in the United States and the Netherlands. It offers Alz1, an at-home lab test kit to measure non-bound copper in the blood; dietary supplement products to reduce blood heavy metals content under the Alz1 Tab brand; and COVID19 rapid test for the detection of IgM and IgG SARS-CoV-2 related antibodies. The company also provides dry aerosol generators for air and inanimate environmental surfaces sanitization, as well as air sterilization and purification devices. In addition, it engages in laboratory analysis. The company was incorporated in 2015 and is headquartered in Hoofddorp, the Netherlands.
Q&A For IGEA Pharma N.V. Stock
What is a current IGPH.SW stock price?
IGEA Pharma N.V. IGPH.SW stock price today per share is 0.0015 CHF.
How to purchase IGEA Pharma N.V. stock?
You can buy IGPH.SW shares on the Swiss exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IGEA Pharma N.V.?
The stock symbol or ticker of IGEA Pharma N.V. is IGPH.SW.
Which industry does the IGEA Pharma N.V. company belong to?
The IGEA Pharma N.V. industry is Diagnostics & Research.
How many shares does IGEA Pharma N.V. have in circulation?
The max supply of IGEA Pharma N.V. shares is 337.03M.
What is IGEA Pharma N.V. Price to Earnings Ratio (PE Ratio)?
IGEA Pharma N.V. PE Ratio is 0.00000000 now.
What was IGEA Pharma N.V. earnings per share over the trailing 12 months (TTM)?
IGEA Pharma N.V. EPS is 0 CHF over the trailing 12 months.
Which sector does the IGEA Pharma N.V. company belong to?
The IGEA Pharma N.V. sector is Healthcare.